-
December 13: The Week in Cancer News
Active surveillance of DCIS patients may be an alternative to treatment, and guidelines add self-test for HPV.
by Kevin McLaughlin
-
December 6: The Week in Cancer News
HPV vaccine credited for decrease in cervical cancer deaths among young women, and new technology extends survival in locally advanced pancreatic cancer.
by Thomas Celona
-
November 22: The Week in Cancer News
Pancreatic cancer surge in younger people has not led to a rise in deaths, and researchers will study long-term survivors to better understand cancer responses.
by Eric Fitzsimmons
-
November 15: The Week in Cancer News
Complications can affect men years after prostate cancer treatment, and many people eligible for lung cancer screening do not get it.
by Kevin McLaughlin
-
November 8: The Week in Cancer News
Early initiation of palliative care leads to fewer hospital admissions, and surgery that removes fewer lymph nodes is effective for localized muscle-invasive bladder cancer.
by Marci A. Landsmann
-
November 1: The Week in Cancer News
Long-term monitoring can catch side effects in childhood cancer survivors, and breast cancer screening rates remain low among transgender people.
by Thomas Celona
-
October 25: The Week in Cancer News
Asian American and Pacific Islander women face rising rates of early-onset breast cancer, and the risk for dying of COVID-19 is twice as high in people living with cancer.
by Eric Fitzsimmons
-
October 18: The Week in Cancer News
Immunotherapy lowers risk of side effects in advanced lymphoma, and an extra course of chemotherapy improves survival in cervical cancer.
by Marci A. Landsmann
-
October 11: The Week in Cancer News
Expanded dependent coverage improves cancer outcomes in young adults, and breast cancer treatment can lead to faster cell aging.
by Kevin McLaughlin
-
October 4: The Week in Cancer News
Study finds people who receive brain radiation often recover cognitive abilities over time, and report details breast cancer trends.
by Thomas Celona
Cancer Talk
Delaying Treatment Resistance
Adding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
Cancer Today Editors’ Picks: 2024Our favorite Cancer Today stories from 2024, as picked by the editors.
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona